Compounds > deamino-arginine-vasopressin

deamino-arginine-vasopressin and Multiple-System-Atrophy

deamino-arginine-vasopressin has been researched along with Multiple-System-Atrophy* in 1 studies

Other Studies

1 other study(ies) available for deamino-arginine-vasopressin and Multiple-System-Atrophy

Article	Year
The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2003, Volume: 13, Issue:2 Nocturnal waking in urination (nocturia) is a common feature in patients with multiple system atrophy (MSA). Degeneration of arginine vasopressin (AVP) neurons in the suprachiasmatic nucleus in this disorder may lead to nocturnal polyuria, which has been treated with intramuscular desmopressin. We also prescribed 5 microg of intranasal desmopressin once a night in 3 MSA patients, who had nocturnal polyuria with abnormal circadian rhythm of the plasma AVP. During the treatment, all patients showed an improvement in their nocturia without serious adverse effects. Topics: Administration, Intranasal; Aged; Circadian Rhythm; Deamino Arginine Vasopressin; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Polyuria; Renal Agents	2003

Article

Year

The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2003, Volume: 13, Issue:2

Nocturnal waking in urination (nocturia) is a common feature in patients with multiple system atrophy (MSA). Degeneration of arginine vasopressin (AVP) neurons in the suprachiasmatic nucleus in this disorder may lead to nocturnal polyuria, which has been treated with intramuscular desmopressin. We also prescribed 5 microg of intranasal desmopressin once a night in 3 MSA patients, who had nocturnal polyuria with abnormal circadian rhythm of the plasma AVP. During the treatment, all patients showed an improvement in their nocturia without serious adverse effects.

Topics: Administration, Intranasal; Aged; Circadian Rhythm; Deamino Arginine Vasopressin; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Polyuria; Renal Agents

2003